Literature DB >> 7907858

Assessment of contributions to disability in people with schizophrenia during rehabilitation.

R O'Connor1, H Herrman.   

Abstract

The aim of this study was to assess a number of the components of disability in patients diagnosed with DSM-IIIR residual schizophrenia. Forty-one patients undergoing hospital and community rehabilitation programs were tested. A range of disability levels was defined with a measure of global assessment of function. A large proportion of the patients also had poor results on frontal lobe testing, persistent positive symptoms, and high levels of emotional distress. There was a trend for higher levels of positive symptoms to be associated with increases in global levels of disability, frontal lobe impairment and emotional distress. The work suggests that rehabilitation programs could be more focused if patients were assessed not only for their overall level of functional disability but also for the level of treatment resistant positive symptoms, frontal lobe impairment and the amount and type of emotional distress and insight.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7907858     DOI: 10.3109/00048679309075821

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  2 in total

1.  Multimodal cognitive therapy: combining treatments that bypass cognitive deficits and deal with reasoning and appraisal biases.

Authors:  Dawn I Velligan; Meredith Draper; Donna Stutes; Natalie Maples; Jim Mintz; Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-07-20       Impact factor: 9.306

2.  A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia.

Authors:  Dawn I Velligan; Sara Tai; David L Roberts; Natalie Maples-Aguilar; Matt Brown; Jim Mintz; Douglas Turkington
Journal:  Schizophr Bull       Date:  2014-09-05       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.